Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats

The aim of this experiment was to evaluate the antioxidants and anti-inflammatory potential of the Biofield Energy Treated/ Blessed Proprietary Test Formulation and Biofield Energy Treatment per se to the animals on Cecal Slurry, LPS, and E. coli - induced systemic inflammatory response syndrome (SIRS) model in Sprague Dawley rats. The parameters like in brain (MMP- 9, FDP, Substance P, iNOS) and in heart (FDP, substance P, iNOS) were analysed using ELISA assay. A test formulation was formulated including minerals (magnesium, zinc, calcium, selenium, and iron), vitamins (ascorbic acid, pyridoxine HCl, vitamin E, cyanocobalamin, and cholecalciferol), cannabidiol (CBD) isolate, Panax ginseng extract, and β-carotene. The constituents of the test formulation were divided into two parts; one section was defined as the untreated test formulation, while the other portion of the test formulation and three group of animals received Biofield Energy Healing Treatment remotely for about 3 minutes by a renowned Biofield Energy Healer, Mr. Mahendra Kumar Trivedi. The level of MMP-9 in brain was significantly ( p ≤0.001) reduced by 48.63%, 36.81%, 40.84%, and 60.03% in the G6 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se to animals from day -15); G7 (Cecal Slurry, LPS and E. coli along with the Biofield Energy Treated test formulation from day -15); G8 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se plus the Biofield Energy Treated test formulation from day -15), and G9 (Cecal Slurry, LPS and E. coli along with Biofield Energy Treatment per se animals plus the untreated test formulation) groups, respectively as compared to the untreated test formulation (G4) group. The level of FDP in brain was significantly reduced by 43.10% ( p ≤0.001), 33.40%, 35.46%, and 62.11% ( p ≤0.001) in the G6, G7, G8, and G9 groups, respectively as compared to the G4 group. The level of substance P was significantly decreased in brain by 18.42% ( p ≤0.001), 53.79% ( p ≤0.001), 16.65%, 14.64%, and 28.43% ( p ≤0.001) in the G5, G6, G7, G8, and G9 groups, respectively as compared to the G4 group. The iNOS level in brain was significantly decreased by 35.92% ( p ≤0.001), 32.80%, 47.20% ( p ≤0.001), and 66.43% ( p ≤0.001) in the G6, G7, G8, and G9 groups, respectively than G4 group. Besides, FDP in heart tissue was significantly decreased by 15.66%, 17.41% ( p ≤0.05), 11.85%, and 13.02% in the G5, G6, G8, and G9 groups, respectively as compared to the G4 group. The levels of heart substance P and iNOS were altered. Overall, the Biofield Energy Treated test formulation and Biofield Energy Treatment per se along with preventive maintenance groups showed an antioxidant and anti-inflammatory potentials. Therefore, the results showed the significant slowdown the inflammation- related disease progression and its complications/symptoms in the preventive groups ( viz. G6, G7, G8, and G9) that might be beneficial various types of systemic inflammatory disorders specially sepsis, trauma, septic shock or any types of injuries.